🔗 Share this article Social Media Content Creators Fueling Parallel Market for Unlicensed Slimming Drug A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings. Investigational Drug Acquiring Traction Online The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers. Thriving Trade on Social Networks Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before directing buyers to WhatsApp for purchases. Learning About The Experimental Drug Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic. Medical Professionals Express Worries Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users injecting products of uncertain source. Several experts stated the demand for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro. Legal Status and Implementation Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012. Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer laws, risking penalties, legal action or prison. Service Reaction and Material Removal According to TikTok, the platform has removed violative content and banned related keywords and search suggestions. The company said it was dedicated to maintaining the service secure and investing in strengthening compliance measures. Digital Marketplace Activities Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, filled with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at home. Within moments of joining one group, a vendor shared contact information, where most transactions occur. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience. Product Details and Pricing Within these communities, messages show dark colored packages with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”. Platform Moderation and Safety Measures A spokesperson for the messaging service said it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Healthcare Expert Warnings “People are administering substances they can’t verify. Although the research behind retatrutide is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U. A medical professional of an online medical service linked the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained. Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.” Manufacturer Position A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially significant health risks”.